REGISTERED
on 08 Aug 2023
Last Applicant/ Owned by
9804 Medical Center Drive
Rockville
MD
20850
Serial Number
97436707 filed on 31st May 2022
Registration Number
7134753 registered on 08th Aug 2023
Correspondent Address
William R. Samuels
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
NAVXCELL
Biotechnological platform technology, namely, cell lines for preparation of biological vectors, and recombinant viruses for gene delivery, that includes recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific production of biologics with therapeutic effect in gene therapy, including gene therapy delivery of antibody biologics, enzymes and RNA interference (RNAi)
Classification Information
Class [005]
Pharmaceutical Products
Biotechnological platform technology, namely, cell lines for preparation of biological vectors, and recombinant viruses for gene delivery, that includes recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific production of biologics with therapeutic effect in gene therapy, including gene therapy delivery of antibody biologics, enzymes and RNA interference (RNAi)
First Use Date in General
05th May 2023
First Use Date in Commerce
05th May 2023
Specimens
Mark Details
Serial Number
No 97436707
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 1959.01
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 08th Aug 2023 | REGISTERED-PRINCIPAL REGISTER |
| 08th Aug 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 06th Jul 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 05th Jul 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 20th Jun 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| 17th Jun 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 17th Jun 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 17th Jun 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 16th Jun 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 24th May 2023 | TEAS STATEMENT OF USE RECEIVED |